EUVIMEDEUVIMED entdecken
Crossref

Identification of Potential Blood-Based Biomarkers for Frailty by Using an Integrative Approach

Mutsumi Suganuma, Motoki Furutani, Tohru Hosoyama, Risa Mitsumori, Rei Otsuka, Marie Takemura, Yasumoto Matsui, Yukiko Nakano, Shumpei Niida, Kouichi Ozaki, Shosuke Satake, Daichi Shigemizu

Gerontology · 2024

DOI: 10.1159/000538313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gerontology, 2024. Verfasst von Mutsumi Suganuma und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology, Obu, Japan. Hauptthemen laut MEDLINE: Biomarkers, Frailty, Frail Elderly. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Although frailty is a geriatric syndrome that is associated with disability, hospitalization, and mortality, it can be reversible and preventable with the appropriate interventions. Additionally, as the current diagnostic criteria for frailty include only physical, psychological, cognitive, and social measurements, there is a need for promising blood-based molecular biomarkers to aid in the diagnosis of frailty.

Methods

To identify candidate blood-based biomarkers that can enhance current diagnosis of frailty, we conducted a comprehensive analysis of clinical data, messenger RNA-sequencing (RNA-seq), and aging-related factors using a total of 104 older adults aged 65–90 years (61 frail subjects and 43 robust subjects) in a cross-sectional case-control study.

Results

We identified two candidate biomarkers of frailty from the clinical data analysis, nine from the RNA-seq analysis, and six from the aging-related factors analysis. By using combinations of the candidate biomarkers and clinical information, we constructed risk prediction models. The best models used combinations that included skeletal muscle mass index measured by dual-energy X-ray absorptiometry (adjusted p = 0.026), GDF15 (adjusted p = 1.46E-03), adiponectin (adjusted p = 0.012), CXCL9 (adjusted p = 0.011), or apelin (adjusted p = 0.020) as the biomarker. These models achieved a high area under the curve of 0.95 in an independent validation cohort (95% confidence interval: 0.79–0.97). Our risk prediction models showed significantly higher areas under the curve than did models constructed using only basic clinical information (Welch’s t test p < 0.001).

Conclusion

All five biomarkers showed statistically significant correlations with components of the frailty diagnostic criteria. We discovered several potential biomarkers for the diagnosis of frailty. Further refinement may lead to their future clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersFrailtyFrail ElderlyHumansAgedMaleFemaleAged, 80 and overCase-Control StudiesCross-Sectional StudiesGrowth Differentiation Factor 15Geriatric AssessmentAgingAdiponectinAbsorptiometry, PhotonApelin

Stichwörter der Autor:innen

Blood-based biomarkerFrailtyPrediction modelRNA-sequencing

Substanzen

BiomarkersGrowth Differentiation Factor 15GDF15 protein, humanAdiponectinApelin

Autor:innen und Institutionen

  • Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology, Obu, Japan.
  • Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Geroscience Research Center, Research Institute, National Center for Geriatrics and Gerontology, Obu, Japan.
  • Center for Gerontology and Social Science, Research Institute, National Center for Geriatrics and Gerontology, Obu, Japan.
  • Center for Frailty and Locomotive Syndrome, National Center for Geriatrics and Gerontology, Obu, Japan.
  • Core Facility Administration, Research Institute, National Center for Geriatrics and Gerontology, Obu, Japan.

Zitieren

APA

Suganuma, M., Furutani, M., Hosoyama, T., Mitsumori, R., Otsuka, R., Takemura, M., Matsui, Y., Nakano, Y., Niida, S., Ozaki, K., Satake, S., & Shigemizu, D. (2024). Identification of Potential Blood-Based Biomarkers for Frailty by Using an Integrative Approach. Gerontology. https://doi.org/10.1159/000538313

Vancouver

Suganuma M, Furutani M, Hosoyama T, Mitsumori R, Otsuka R, Takemura M, et al. Identification of Potential Blood-Based Biomarkers for Frailty by Using an Integrative Approach. Gerontology. 2024. doi:10.1159/000538313

BibTeX
@article{Suganuma2024,
  author = {Suganuma, Mutsumi and Furutani, Motoki and Hosoyama, Tohru and Mitsumori, Risa and Otsuka, Rei and Takemura, Marie and Matsui, Yasumoto and Nakano, Yukiko and Niida, Shumpei and Ozaki, Kouichi and Satake, Shosuke and Shigemizu, Daichi},
  title = {Identification of Potential Blood-Based Biomarkers for Frailty by Using an Integrative Approach},
  journal = {Gerontology},
  year = {2024},
  doi = {10.1159/000538313}
}
Kostenlos starten →